As hospitals and health systems grapple with the promise and pitfalls of artificial intelligence, a growing body of evidence suggests that the bottleneck in successful AI deployment is not the algorithm itself, but the infrastructure required to support it. Despite significant investment—healthcare organizations spent an estimated $3.7 billion on AI solutions in 2025, according to Statista—approximately three-quarters of AI pilots never reach production, a trend highlighted in Gartner’s 2025 analysis of digital health implementations.
This pattern has prompted a reevaluation of where the true challenges lie. While early assumptions pointed to model accuracy, data quality, or clinician resistance as primary barriers, industry observers are increasingly identifying a systemic gap in deployment infrastructure. The issue is not whether an algorithm works in a controlled environment, but whether it can be safely integrated into clinical workflows, monitored for compliance, and sustained over time without introducing risk.
The concept of a “platform gap” has emerged to describe this disconnect. When a clinical decision support tool powered by machine learning moves from pilot to production, it must meet a range of operational and regulatory demands: seamless integration with electronic health record (EHR) systems, immutable logging of every inference for auditability, graceful degradation when data inputs fail, and adherence to HIPAA and emerging state-level AI transparency laws. These requirements are not inherent to the model but fall squarely within the domain of platform engineering.
Industries that have navigated similar terrain offer instructive parallels. In financial services, the deployment of AI for Bank Secrecy Act/Anti-Money Laundering (BSA/AML) compliance, fraud detection, and suspicious activity monitoring revealed that regulatory approval depended not just on algorithmic performance but on verifiable governance. The Office of the Comptroller of the Currency and the Financial Crimes Enforcement Network (FinCEN) required explainability, audit trails, and oversight mechanisms independent of any single model. In response, banks developed internal platforms that decoupled model development from model governance—a structural shift now being mirrored in healthcare, where the stakes are arguably higher due to the direct impact on patient care.
Three core disciplines are emerging as foundational to healthcare AI platform engineering. First is policy-as-code, which encodes regulatory and compliance requirements directly into deployment pipelines. This allows organizations to respond dynamically to changes—such as updates from the Centers for Medicare & Medicaid Services (CMS) or modern state-level AI disclosure laws—by propagating adjustments across all deployed models in real time, reducing compliance lag from months to hours.
Second is the implementation of automated, immutable audit trails. Every model inference, data access event, and configuration change must be logged in a tamper-proof manner. The U.S. Department of Health and Human Services Office for Civil Rights has indicated that AI-driven decisions involving protected health information will be subject to the same scrutiny as traditional data handling under HIPAA. Organizations lacking this infrastructure risk accumulating compliance debt that could culminate in regulatory penalties or erosion of trust.
Third is the development of internal developer platforms tailored to clinical AI. These platforms abstract away complex, healthcare-specific requirements such as FHIR-based data exchange, patient consent management, data de-identification workflows, and role-based access controls. By handling these layers systematically, they enable data science teams to focus on model innovation rather than rebuilding compliance infrastructure for each new project.
Organizations that have embraced this platform-centric approach report measurable advantages. According to KLAS Research, health systems with mature deployment infrastructure achieve up to 40% faster time-to-market for AI initiatives compared to those constructing bespoke pipelines for each project. Standardization reduces the marginal cost of deploying subsequent models, creating long-term efficiency gains.
For chief information officers and chief technology officers in health systems, the strategic implication is clear: prioritize platform readiness before pursuing new algorithms. Key questions include whether existing infrastructure can support production-grade AI, whether compliance can be demonstrated for any model at any time to regulators, and whether data science teams can deploy new models without reconstructing governance from scratch. If the answer to any of these is negative, the next investment should not be another algorithm, but the platform that enables safe, scalable, and compliant deployment.
The healthcare industry does not face a shortage of innovative algorithms. Instead, it confronts a structural deficit in the systems needed to bring those innovations responsibly to patients. Addressing this gap—by building platforms that ensure safety, accountability, and adaptability—represents one of the most consequential infrastructure decisions health systems will make this decade.
Piyoosh Rai is the founder and chief executive officer of The Algorithm, a technology firm specializing in AI platform engineering for regulated industries, including healthcare and financial services. The company is based in Littleton, Colorado, and focuses on helping organizations build the infrastructure necessary to deploy AI safely and at scale.